Trials / Conditions / Preterm Premature Rupture of Membranes

Preterm Premature Rupture of Membranes

12 registered clinical trials studyying Preterm Premature Rupture of Membranes.

Status	Trial	Sponsor	Phase
Unknown	Melatonin, Soluble Urokinase-type Plasminogen Activator Receptor, and Orosomucoid 2 Levels in PPROM NCT04588220	Cengiz Gokcek Women's and Children's Hospital	—
Unknown	Matrix Metalloproteinase 14, Neopterin, and Orosomucoid 1 Levels in PPROM NCT04532021	Cengiz Gokcek Women's and Children's Hospital	—
Completed	Multimodal Monitoring of Fetal Risk of Inflammation in Preterm Premature Rupture of Membranes NCT02702297	Martin-Luther-Universität Halle-Wittenberg	—
Unknown	The Relation Between Serum Ascorbic Acid Concentration and Preterm Premature Rupture of Membranes NCT02635451	Ain Shams Maternity Hospital	—
Completed	Cervical Ripening in Premature Rupture of Membranes NCT02314728	Montefiore Medical Center	N/A
Unknown	Preterm Premature Rupture of Membranes, Outpatient Management vs Inpatient Management NCT02548013	Ain Shams Maternity Hospital	N/A
Unknown	Pomegranate to Reduce Maternal and Fetal Oxidative Stress and Improve Outcome in Pregnancies Complicated With NCT01584323	Rambam Health Care Campus	N/A
Completed	PPROM Erythromycin Versus Azithromycin NCT01431248	University of Oklahoma	—
Completed	Does Vitamins C and E Supplementation of After Preterm Rupture of Membranes Prolong the Duration of Latency? A NCT01266928	Erzincan Military Hospital	Phase 3
Unknown	Va-Sense - Bacterial Vaginosis Once A Week Screening And Treatment To Reduce Infective Complications, Abortion NCT01152528	Common Sense	Phase 3
Unknown	Indomethacin Versus Placebo in Women With Preterm Premature Rupture of Membranes (PPROM) NCT00466128	Thomas Jefferson University	Phase 2
Terminated	Magnesium Sulfate Versus Placebo for Tocolysis in PPROM NCT00463736	Regional Obstetrical Consultants	N/A